CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 102 filers reported holding CONCERT PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $612,000 | -0.8% | 48,453 | -22.9% | 0.00% | 0.0% |
| Q3 2020 | $617,000 | +115.0% | 62,853 | +117.9% | 0.00% | 0.0% |
| Q2 2020 | $287,000 | +46.4% | 28,850 | +30.4% | 0.00% | 0.0% |
| Q1 2020 | $196,000 | +53.1% | 22,126 | +59.2% | 0.00% | – |
| Q4 2019 | $128,000 | -97.1% | 13,900 | -95.3% | 0.00% | -100.0% |
| Q3 2018 | $4,420,000 | -12.9% | 297,864 | -1.3% | 0.01% | -16.7% |
| Q2 2018 | $5,077,000 | -24.1% | 301,650 | +3.3% | 0.01% | -20.0% |
| Q1 2018 | $6,686,000 | +137.8% | 291,950 | +168.6% | 0.02% | +114.3% |
| Q4 2017 | $2,812,000 | – | 108,700 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 2,610 | $620,000,000 | 6.47% |
| Parkman Healthcare Partners LLC | 1,124,072 | $4,732,000 | 1.74% |
| Kynam Capital Management, LP | 1,000,000 | $4,210,000 | 1.08% |
| EAM Investors, LLC | 850,647 | $3,581,000 | 0.87% |
| BVF INC/IL | 3,629,000 | $15,278,000 | 0.74% |
| EAM Global Investors LLC | 388,730 | $1,637,000 | 0.40% |
| RA Capital Management | 3,307,203 | $13,923,000 | 0.37% |
| Nantahala Capital Management | 1,659,840 | $6,988,000 | 0.35% |
| AWM Investment Company, Inc. | 504,661 | $2,125,000 | 0.34% |
| INGALLS & SNYDER LLC | 1,411,153 | $5,941,000 | 0.31% |